Any idea??? Info please
My Group. Dr Lesley move moved things up on our timetable.
pierre, open your eyes watching EXEL,
IT IS GOING TO SPIKE WITH TAKEOVER DEAL. EXEL HAS 30 drug candidate in the level of preclinical trial to phase III clinical trials. EXEL is on good cash position. so EXEL is one of the best take over candidate.
Sentiment: Strong Buy
that was us , we only buy butout candidates right now our largest holdings, DNDN,ARRY,IGXT and EXEL. Recently large buyers of HGSI, ANDS
anyone following GALE/galena bio ? still under $2 w/possible vaccine for breast cancer.
what drugs are you on?
What are you talking about